Genomic surveillance and sequencing of SARS-CoV-2 in Malaysia
-
Published:2024-04-16
Issue:
Volume:
Page:71-83
-
ISSN:2672-7277
-
Container-title:Asia Pacific Journal of Molecular Biology and Biotechnology
-
language:en
-
Short-container-title:APJMBB
Author:
Tajudin Norazimah1, Wang Seok Mui2, Kumar Darshan Chandra3, Mohamad Mariam4, Mohd Nawi Siti Farah Alwani2
Affiliation:
1. National Public Health Laboratory, Ministry of Health Malaysia, Sungai Buloh, Selangor, Malaysia 2. Department of Medical Microbiology and Parasitology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Selangor, Malaysia 3. Kolej Yayasan UEM, Lembah Beringin, P.O. Box 62, Tanjung Malim, Selangor, Malaysia 4. Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Selangor, Malaysia
Abstract
This manuscript offers an in-depth review of the genomic surveillance of SARS-CoV-2 variants in Malaysia, emphasizing the integral role of this surveillance in understanding the virus's evolution and informing public health responses. Leveraging platforms like GISAID, Nextstrain, and the Pangolin classification system, researchers in Malaysia and their global counterparts share genome sequences and clinical data of SARS-CoV-2. These tools, particularly Nextstrain for real-time tracking and visualization of viral evolution, and Pangolin for lineage classification have advanced understanding of significant mutations, such as D614G and N501Y, and their impact on virus transmissibility and pathogenicity. The study of the virus's emergence in Malaysia offers vital insights into its evolutionary trajectories, aiding in effective pandemic management. Malaysia's Genomic Surveillance Program, aligned with national immunization efforts, plays a key role in identifying and controlling COVID-19 spread. This program integrates molecular, epidemiological, and clinical data that helps the health authorities in making a decision that leads to public health intervention and policymaking. This review details the significance of genomic surveillance in Malaysia, emphasizing its impact on understanding viral evolution, monitoring variants, informing public health strategies and responses, and preparing for future infectious disease challenges effectively.
Publisher
Malaysian Society for Molecular Biology and Biotechnology
Reference80 articles.
1. Adam, A. 2021. Dr Noor Hisham: SOPs for arrivals into country tightened to mitigate risk of Covid-19 variants. Malay Mail. https://www.malaymail.com/news/malaysia/2021/06/24/dr-noor-hisham-sops-for-arrivals-into-country-tightened-to-mitigate-risk-of/1984726. Accessed April 6, 2022. 2. Alpha Malaysia GISAID Initiative. (n.d). https://www.epicov.org/epi3/frontend#e8216. Accessed January 19, 2024. 3. Ao, D., He, X., Hong, W., & Wei, X. 2023. The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants. MedComm 4(2): e239. 4. Azami, N. A. M., Perera, D., Thayan, R., Bakar, S. A., Sam, I.-C., Salleh, M. Z., Mat Isa, M. N., Ab Mutalib, N. S., Aik, W. K., Suppiah, J., Tan, K.-K., Chan, Y. F., Teh, L. K., Azzam, G., Mohamed Rasheed, Z. B., Jui Chan, J. C., Kamel, K. A., Tan, J.-Y., Khalilur Rahman, O. et al. 2022. SARS-CoV-2 genomic surveillance in Malaysia: Displacement of B.1.617.2 with AY lineages as dominant Delta variants and the introduction of Omicron during the fourth epidemic wave. International Journal of Infectious Diseases 125: 216–226. 5. Malaysia Beta GISAID Initiative. (n.d.). https://www.epicov.org/epi3/frontend#232aec. Accessed January 19, 2024.
|
|